Omacetaxine Mepesuccinate: A New Treatment Option for Patients With Chronic Myelogenous Leukemia

類似資料

• Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia
  著者:: Chen, Yaoyu, 等
  出版事項: (2014)
• Incidence and management of myelosuppression in patients with chronic- and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate
  著者:: Akard, Luke, 等
  出版事項: (2015)
• Omacetaxine: a protein translation inhibitor for treatment of chronic myelogenous leukemia
  著者:: Gandhi, Varsha, 等
  出版事項: (2014)
• U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia
  著者:: Alvandi, Firoozeh, 等
  出版事項: (2014)
• Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors
  著者:: Nicolini, Franck E., 等
  出版事項: (2013)